415nok
6,1 %
Date:2025-09-11Time:18:00:00Latest report:Q2-2025List:Oslo GrowthTicker:ABS
Market Cap:105 mnokEnterprise Value:158 mnokNet Sales:44,0 mnokEarnings:-43,4 mnokEmployees:0ISIN:NO0010859580
Ratios
10-year key figure history for Arctic Bioscience turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Arctic Bioscience with index and moving average MA50 and MA200.
Stockprice:4,15
MA50:3,75
MA200:3,42
Price/MA200:21,4 %
RSI (14):57,8
Price/MA50:10,7 %
Description
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a new drug candidate for the treatment of patients with mild-to-moderate psoriasis. Their dietary supplements are sold globally both as bulk ingredients and as finished products under the ROMEGA brand, to both corporate and private customers.